Transcript Document 3069490

7th Framework Program
2007-2013
Achilleas D. Stalios
[email protected]
European Commission -DG ResearchIndustrial Technologies Directorate -Materials-
Funding programmes

Education
- Lifelong Learning Programme

Research- FRAMEWORK PROGRAMMES
- Seventh Framework Programme for research and
development

Innovation
- Competitiveness and Innovation Programme

Structural and Cohesion Funds
R&D – European weaknesses
R&D intensity (% of GDP)
(3)
Share of R&D financed by industry (%)
(2)
Researchers per thousand labour force (FTE)
Share of world scientific publications (%)
(3)
Scientific publications per million population
Share of world triadic patents (%)
(3)
(3)
(1)
Triadic patents per million population
(1)
High-tech exports as a share of total manufacturing
exports (%) (3)
Share of world high-tech exports (%)
Note: (1) 2000 data
(2)
2002 data
(3)
2003 data
(2)
EU-25
US
Japan
1.97
2.59
3.12
55.9
63.1
73.9
5.5
9.0
9.7
38.3
31.1
9.6
639
809
569
31.5
34.3
26.9
30.5
53.1
92.6
19.7
28.5
26.5
16.7
20.0
10.6
Towards
The 7th Framework Programme
2007-2013 (‘co-decision’)
FP7 : What’s new?
New
FP7
http://ec.europa.eu/research/fp7/events/07_feb_07_prog_en.html
Main
elements:
 Duration increased to seven years
 Total budget of €50.5 billion=>63% increase
 Frontier research (~ €1.1 billion per year)
 New structure:
Cooperation – Ideas – People – Capacities
 Flexible funding schemes
 Joint Technology initiatives
 Simpler procedures
 Outsourcing
FP7 2007 –2013
Specific Programmes
Cooperation – Collaborative research
Ideas – Frontier Research
People – Marie Curie Actions
Capacities – Research Capacity
+
JRC (non-nuclear)
JRC (nuclear)
Euratom
FP7/ Budget
Cooperation
32 413 €M
Ideas
7 460 €M
People
4 728 €M
Non-nuclear JRC
1 751 €M
Capacities
4 217 €M
Total European Community budget for non-nuclear research:
50.52 € billions
FP7/ Cooperation programme
http://cordis.europa.eu/fp7/cooperation
FP7/ Cooperation programme
Funding Schemes
• Collaborative projects
– Projects can range from small or medium-scale focused
research actions (CP)
– Large-scale integrating projects for achieving a defined
objective. (Large CP)
• Coordination and support actions
– Support for activities aimed at coordinating or
supporting research activities and policies (networking,
exchanges, trans-national access to research
infrastructures, studies, conferences, etc.). (CA) and
(SSA)
• Networks of Excellence
FP7 /Cooperation programme
(collaborative research)
10 Themes
M€
1. Health
6 100/628 19 April
2. Food, agriculture & fisheries and biotechnology
1 935/192
3. Information Society and Communication
Technologies -> ICT
9 050/1019 8 May
4. Nanosciences, nanotechnologies, Materials
& new Production technologies -> NMP
3 475/364 4May1st
5. Energy
2 350/237 3 May
6. Environment (including climate change)
1 890/200 2 May
7. Transport (including aeronautics)
4 160/229 3 May
8. Socio-economic sciences & the humanities
2 May
623/58.5 10 May
9. Security
1 400/34.5 19 Jun
10. Space
1 430/80.3 31 May
4. Nanosciences,
Nanotechnologies, Materials
and new Production
Technologies
• Nanosciences and nanotechnologies
• Materials
• New production
• Integration of technologies for
industrial applications
Workprogrammes include indicative
priorities for future calls!!!
Selected topics in Materials and
Nanotechnology in FP7
Nanomaterials
NMP-2007-2.1.1 Nanostructured polymer-matrix composites
Large CP
NMP-2007-2.1.2 Nanostructured coatings and thin films
CP
NMP-2007-2.2-1 Organic materials for electronics and photonics
Large CP
NMP-2007-2.2-2 Nanostructured materials with tailored magnetic properties
CP
NMP-2007-2.2-3 Advanced material architectures for energy conversion
CP
NMP-2007-2.3-1 Highly porous bioactive scaffolds controlling angiogenesis
Large CP
for tissue engineering
NMP-2007-2.4-2 Nanostructured catalysts with tailor-made functional surfaces
CP
NMP-2007-2.4-3 Renewable materials for functional packaging applications
CP
NMP-2007-2.5-2 Modelling of microstructural evolution under work conditions
CP
and in materials processing
Nanomaterials –cont’d
ENERGY-2007.1.2.4
Novel nanostructured materials for hydrogen storage
CP
ENERGY-2007.1.1.1
CP
ENERGY-2007.1.1.2
Basic research for materials and processes for Polymer
Electrolyte Membrane Fuel Cells (PEMFC)
CP
Basic research on materials and processes for High Temperature
Fuel Cells (SOFC & MCFC)
ENERGY-2007.1.2.1
New materials and processes for advanced electrolysers
CP
ENERGY-2007.1.2.2
New materials and processes for advanced multi-fuel processors
CP
AAT-2007.1.1.2
Aerostructures
CP, CSA
Nanoelectronics
ICT-2007.3.1
CP, NoE, CSA
Next generation nanoelectronics components and electronics
integration
ICT-2007.8.1
Nano-scale ICT devices and systems
CP, CSA (CA only)
Nanoscience
NMP-2007-1.1-1
Nano-scale mechanisms of bio/non-bio interactions
CP
NMP-2007-1.1-2
Self-assembling and self-organisation
CP
NMP-2007-1.1-3
CSA
NMP-2007-1.1-4
CSA
NMP-2007-1.1-5
CSA (ERANET)
Support to ICPC researchers in nanotechnology and
creation of a free and open electronic archive of
nanosciences and nanotechnologies scientific and
technical publications
Development of methodology, collection and elaboration of
scientific-technical and socio-economic data and studies
on nanosciences and nanotechnologies, including risk
assessment, and establishment of an observatory
ERANET Plus in nanosciences
Technology development
NMP-2007-1.2-1
Large CP
Pilot lines to study, develop and up-scale nanotechnologybased processes from laboratory
NMP-2007-1.2-2
Equipment and methods for nanotechnology
SME-targeted CP
NMP-2007-1.2-3
CSA
Analysis of the ethical, regulatory, social and economic
environment of nanomedicine
NMP-2007-1.2-4
Coordination in nanometrology
CSA
NMP-2007-1.2-5
Examining capacity building in nanobiotechnology
CSA
NMP-2007-3.4-1
SME-targeted CP
NMP-2007-3.5-1
Large CP
NMP-2007-3.5-2
Rapid Manufacturing Concepts for Small Series Industrial
Production
Processes and Equipment for High Quality Industrial
Production of 3-Dimensional Nanosurfaces
Large CP
Production Technologies and equipment for MicroManufacturing
NMP-2007-4.0-3
Multifunctional materials for future vehicles
SME-targeted CP
Impact assessment and societal issues
NMP-2007-1.3-1
Large CP
NMP-2007-1.3-2
CP
NMP-2007-1.3-3
CSA
NMP-2007-1.3-4
CSA
NMP-2007-1.3-5
CSA
HEALTH-2007-1.3-4
Specific, easy-to-use portable devices for measurement and
analysis
Risk assessment of engineered nanoparticles on health and
the environment
Scientific review on the data and studies on the potential
impact on health, safety and the environment of engineered
nanoparticles
Creation of a critical and commented database on the health,
safety and environmental impact of nanoparticles
Coordination in studying the environmental, safety and health
impact of engineered nanoparticles and nanotechnology
based materials and products
CP
Alternative testing strategies for the assessment of the
toxicological profile of nanoparticles used in medical
diagnostics
SiS-2007-1.2.3.2-CT
Science in Society: Nanoscience and Nanotechnology
CSA
Nanomedicine
NMP-2007-4.0-4
Large CP
HEALTH-2007-2.4.1-7
CP
HEALTH-2007-1.2.3
Large CP
HEALTH-2007-1.4.4
Large CP
2nd
call
ICT-2007-5.1
Large CP, CSA
Substantial innovation in the European medical industry:
development of nanotechnology-based systems for invivo diagnosis and therapy (in coordination with topics
HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3)
Improving targeted drug delivery to cancer cells for
cancer therapeutics other than gene therapy
Novel targeted imaging probes for early in vivo diagnosis
and/or evaluation of response to therapy
Development of emerging gene therapy tools and
technologies for clinical application
Personal Health Systems for Monitoring and Point-of-Care
diagnostics
Other Important Topics
ICT-2007.3.6
Micro/nanosystems
CP, NoE, CSA 2nd call*
ICT-2007.3.5
CP, NoE, CSA
2nd
Photonic components and subsystems
call
ICT-2007-C
CP, CSA (CA only)
AAT-2007.6.1.4
CP, CSA
KBBE-2007-2-3-04
FET (Future and Emerging Technologies) Open
(Open call for bottom-up activities)
Life-cycle [of air vehicles, including increased use of
nanotechnologies]
CP
Nano-devices for quality assurance, food safety and
product properties
KBBE-2007-2-4-04
Innovative and safe packaging
CP
KBBE-2007-2-5-02
CP
Converging technologies and their potential for the
food area
* 2nd for ICT call will be public May/June 2007
FP7 /Collaborative projects
Evaluation Criteria
1. S/T quality
2. Implementation
3. Impact
• Sound concept, and
quality of objectives
• Appropriateness of the
management structure
and procedures
• Contribution to impacts
listed in the work
programme under
relevant topic/activity
• Appropriateness of
dissemination and/or
exploitation of projects
results, plans
(in relation to the topics
addressed by the call)
• Progress beyond the
state-of-the-art
• Quality and
effectiveness of the S/T
methodology and work
plan
• Quality and relevant
experience of the
individual participants
• Appropriate allocation
and justification of
committed resources
Potential Joint Technology Initiative:
–
–
–
–
–
–
New Nanoelectronics Approaches
Hydrogen and Fuel Cells for Sustainable Energy Future
Aeroanutics and Air Transport
Global Monitoring for Environment and Securitu
Embedded Systems
Innovative Medicines Initiative
Technology Platforms related to Theme 4:
–
–
–
–
–
–
–
–
–
–
–
–
ENIAC: European Nanoelectronics Initiative Advisory Council
NanoMedicine- Nanotechnologies for Medical Applications
Technology Platform on Sustainable Chemistry
Steel
Future Textiles & Clothing
Manufacturing Technologies
The European Construction Technology Platform
Industrial Safety
The European Hydrogen and Fuel Cell Technology Platform
The European Technology Platform on Photovoltaics
Photonics 21: The Photonics Technology Platform
EUMAT: European TP for Advanced Engineering Materials and
Technologies
– European Aluminum Technology Platform
FP7/ Ideas
http://cordis.europa.eu/fp7/ideas
• Frontier research
• Investigator-driven
• Support to individual teams through
Europe-wide competition
• Governance: European Research Council
• Executive Agency
FP7/ Ideas
Scientific Council
• 22 high level scientists reflecting the full scope of European
research, nominated by Commission
Dr. Claudio BORDIGNON (IT)
Prof. Dr. Paul J. CRUTZEN (NL)
Dr. Daniel ESTEVE (FR)
Prof. Dr. Hans-Joachim FREUND (DE)
Prof. Dr. Carl-Henrik HELDIN (SE)
Prof. Dr. Michal KLEIBER (PL)
Prof. Maria Teresa V.T. LAGO (PT)
Prof Robert MAY (UK)
Prof. Christiane NÜSSLEIN-VOLHARD (DE)
Prof. Alain PEYRAUBE (FR)
Prof. Salvatore SETTIS (IT)
http://europa.eu.int/erc/
Professor Manuel CASTELLS (ES)
Prof. Mathias DEWATRIPONT (BE)
Prof. Pavel EXNER (CZ)
Prof. Wendy HALL (UK)
Prof. Dr. Fotis C. KAFATOS (GR)
Prof. Norbert KROO (HU)
Dr. Oscar MARIN PARRA (ES)
Prof. Helga NOWOTNY (AT)
Dr. Leena PELTONEN-PALOTIE (FI)
Dr. Jens R. ROSTRUP-NIELSEN (DK)
Prof. Dr. Rolf M. ZINKERNAGEL (CH)
FP7 / Ideas
Role of the Scientific Council
• Establish overall scientific strategy and
preparation of work programmes (incl. calls for
proposals, evaluation criteria)
• Define scientific management: peer review
methodology; selection and accreditation of experts;
monitor quality of operations and evaluate
programme implementation
• Assure communication
community
with
the
scientific
FP7 / Ideas
Work Programme / Launch strategy
Two streams of activity are foreseen:
- Early stage independent investigators
(“Starting Grants”)
> 2 < 9 years after PhD
up to 5 years project
~1/3 of the annual budget:
300-350 M€ per year (200 grants)
- Established Investigators (“Advanced
Grants”)
FP7 / IDEAS
Starting Grants / Evaluation criteria
1. Principal Investigator: Potential to perform world class research
Quality of research output: Has the Principal Investigator published in high quality peer reviewed
journals or the equivalent? To what extent are these publications ground-breaking and demonstrative
of independent creative thinking and capacity to go significantly beyond the state of the art?
Intellectual capacity and creativity: To what extent does the Principal Investigator's record of research
collaborations, project conception, supervision of students and publications demonstrate that he/she
isable to confront major research challenges in the field, and to initiate new productive lines of
thinking?
2. Quality of the proposed research project
Ground-breaking nature of the research: Does the proposed research address important challenges in
the field(s) addressed? Does it have suitably ambitious objectives, which go substantially beyond
thecurrent state of the art (e.g. including trans-disciplinary developments and novel or unconventiona
approaches)?
Potential impact: Does the research open new and important scientific, technological or scholarly
horizons?
Methodology: a) is the outlined scientific approach (including the activities to be undertaken by the
individual team members) feasible? (Stage 1) b) is the proposed research methodology (including
when pertinent the use of instrumentation, other type of infrastructures etc.) comprehensive and
appropriate for to the project? Will it enable the goals of the project convincingly to be achieved within
the timescales and resources proposed and the level of risk associated with a challenging research
project? (Stage 2)
3. Research Environment
Transition to independence: Will the proposed project enable the Principal Investigator to make or
consolidate the transition to independence?
Hosting institution (normally applicant legal entity): Does the institution hosting the project have
most of the infrastructure necessary for the research to be carried out? Is it in a position to provide an
appropriate intellectual environment and infrastructural support and to assist in achieving the
ambitions for the project and the Principal Investigator?
Participation of other legal entities: If it is proposed that other legal entities participate in the
project, in addition to the applicant legal entity, is their participation fully justified by the
scientificadded value they bring to the project?
FP7 / IDEAS
Starting Grants / Evaluation criteria
FP7 / Ideas
Starting Grants / Peer review panel
Social Sciences
SH1 Individuals and organisations: Economics, management,
demography, geography, urban and environmental studies.
SH2 Institutions, behaviour, values and beliefs: Anthropology,
sociology, political science, law, communication, social studies of
science and technology.
SH3 The human mind and its complexity: Cognition, linguistics,
psychology and philosophy.
SH4 Cultures and cultural diversity: Literature, visual and
performing arts, music and cultural studies.
SH5 The study of the past and of cultural artefacts: Memory,
history and archaeology.
FP7 / Ideas
Starting Grants / Peer review panel
Natural Sciences & Engineering
PE1 Mathematical foundations: Pure and applied mathematics, theoretical computer
science and mathematical physics.
PE2 Fundamental constituents of matter: High energy, particle, nuclear, plasma,
atomic, molecular, gas and optical physics.
PE3 Structures and reactions: Condensed matter (structure, electronic properties,
fluids,…), statistical physics, nanosciences, reactions.
PE4 Material sciences and methods: Material sciences, molecular architecture,
analytical chemistry, synthesis (both inorganic and organic) and theory,
physical and environmental chemistry, method development.
PE5 Information and communication: Informatics and information systems,
communication technology, computer science, intelligent systems.
PE6 Engineering sciences: Electronics, product design, process design & control,
construction methods, fluid and solid mechanics, energy systems, bioengineering.
PE7 Universe sciences: Astro-physics/chemistry/biology/geology; solar system;
stellar, galactic and extragalactic astronomy; cosmology; space sciences,
instrumentation.
PE8 Earth system science: Physical geography, geology, geophysics,
oceanography, climatology, ecology, global change, biogeochemical cycles,
natural resources.
FP7 / IDEAS
Starting Grants / Peer review panel
Life Sciences
LS1 Molecular, cellular and developmental biology: Biochemistry, molecular biology,
metabolism, cell biology, signal transduction, embryology, structural biology.
LS2 Genetics, genomics, bioinformatics and systems biology: Molecular genetics, cell
genetics, genomics, transcriptomics, metabolomics, computational biology, biostatistics,
biological modelling.
LS3 Organismic physiology, including infection and immunity: Organogenesis, organ
physiology, endocrinology, ageing, toxicology, parasitology, microbiology, virology,
immunology.
LS4 Neurosciences: Neurobiology, neuroanatomy, neurophysiology, neurochemistry,
neuropharmacology, systems neuroscience, neuroimaging.
LS5 Evolutionary, population and environmental biology: Evolution, adaptation,
population biology, biodiversity, ecotoxicology, marine biology, radiation biology,
environmental risks, environmental medicine.
LS6 Applied medical and health sciences: Clinical medicine, public health, psychiatry,
surgery, epidemiology, biomedical engineering, veterinary medicine, pharmacology,
medical ethics.
LS7 Applied biology and bioengineering, including agricultural sciences and
biotechnology: Genetic engineering, GMOs, synthetic biology, plant biology,
fisheries, forestry,environmental biotechnology, industrial biotechnology,
biomaterials, biohazards
FP7 / People
Human potential
OBJECTIVE-> TO MAKE EUROPE MORE ATTRATIVE
FOR THE BEST RESEARCHERS
http://cordis.europa.eu/fp7/people
Scope
• Human resource development in R&D in Europe
• Numerous, well-trained, motivated researchers
• Attract students to research careers
• Attract researchers to Europe and retain skills
and sustainable career development
• Appropriate gender balance
FP7 / People
Activities/ 1st calls for proposals
• Initial training of researchers
- Marie Curie Networks
FP7-PEOPLE-2007-1-1-ITN
7 May-25 Sept 2007
• Life-long training and career development
– Individual Fellowships (IEF)
FP7-PEOPLE-2007-2-1-IEF
14 August 2007
- Co-financing of regional/national/international programmes
FP7-PEOPLE-2007-2-3-COFUND
17 Oct 2007
• Industry-academia pathways and partnerships
- Industry-Academia Scheme
FP7-PEOPLE-2007-3-1-IAPP
31 May 2007
FP7 / People
Activities/1st call for proposals
• International dimension
- Outgoing International Fellowships
FP7-PEOPLE-2007-4-1-IOF
14 August 2007
- Incoming International Fellowships
FP7-PEOPLE-2007-4-2-IIF
14 August 2007
- Reintegration grants
FP7-PEOPLE-2007-4-3-IRG
Continuous submission with "cut-off dates" for
proposals received until 25 April and 17 Oct 2007
• Specific actions
- Excellence awards
FP7-PEOPLE-2007-5-2-AWARDS
- Researchers' night
FP7-PEOPLE-2007-5-1-1-NIGHT
29 March 2007
3 April 2007
FP7 / Capacities
Research Capacity
OBJECTIVE-> TO UNDERPIN THE NEEDS TO
PERFORM RESEARCH
http://cordis.europa.eu/fp7/capacities
•
Research Infrastructures
INFRA-2007-2-2.27 Pan-
European R I for Nano-structures
•
Research benefit of SMEs FP7-SME-2007-1
•
•
Regions of Knowledge
126 M€
Research Potential
340 M€
•
Science in Society
330 M€
•
•
International Cooperation
180 M€
Coherent Development of Policies
1715 M€
1336 M€
70 M€
Conditions for participation
• Minimum condition, general rule, at least 3 independent
participants from 3 different MS or Ac
• Additional conditions can be established by the SP or WP
(number or type of participant, place of establishment)
• Specific conditions may also apply for:
– Frontier research actions, at least 1 legal entity
established in a MS or Ac
– Collaborative projects addressing the participation of
International Cooperation Partner Countries (ICPC)
minimum is 4 participants, 2 of which from MS or Ac and
another 2 from ICPC countries unless otherwise foreseen
in the WP
Upper funding limits (1)
• Reimbursed will be according to the type of action
and/or activity
• Research and technological development activities:
up to 50% of eligible costs, or up to 75% for:
•
•
•
•
•
Non profit public bodies
secondary and higher education establishments
research organisations
SMEs
Security related research, for highly reliable capabilities with
impact on security of European citizens and targeted to a
limited number of public users
• Demonstration activities: up to 50%
• Other activities including management: up to 100%
Upper funding limits (2)
Actions that will be reimbursed up to 100%:
• Frontier research
• Coordination and support actions
• Training and career development of researchers
Maximum
reimbursement
rates of
eligible costs
Research and
technological
development (*)
Network of
excellence
50%
75% (***)
Collaborative
project
50%
75% (***)
Coordination
and support
action
Demonstration
activities
50%
Management
of the
consortium
activities
Other
activities
(**)
100%
100%
100%
100%
100% (****)
100% (****)
(*) Research and technological development includes operational activities directly related to the protection of foreground and
coordination of research activities.
(**) Other activities means any "specific activity" covered by Annex I.
(***) For beneficiaries that are non profit public bodies, secondary and higher education establishments, research organisations and
SMEs
(****) The reimbursement of indirect eligible costs, in the case of coordination and support actions, may reach a maximum 7% of the
direct eligible costs, excluding the direct eligible costs for subcontracting and the costs of reimbursement of resources made
available by third parties which are not used on the premises of the beneficiary.
Reimbursement of eligible costs
• Most funding schemes, particularly at beginning of FP7 will
use reimbursement of eligible costs
Eligible
• actual (average personnel costs may be used if do not
differ significantly from actual)
• incurred during duration of project
• in accordance with the beneficiary usual accounting and
management principles
• recorded in the accounts of beneficiary
• used for the sole purpose of achieving the objectives of the
project
Non-eligible (identifiable indirect taxes including VAT…)
Indirect Cost
• Participants may charge eligible direct and indirect costs
• Reimbursement of indirect costs:
– For all:
• either actual overhead, or simplified method, or
• flat rate of 20% of direct costs
– For Non profit Public Bodies, Secondary and Higher
Education establishments, Research Organisations,
and SMEs unable to identify real indirect costs, may apply
for a flat rate of 60% for funding schemes with Research,
Technological Development & Demonstration
– For Coordination and Support Actions limit of
7% of direct costs
Certification on the methodology
• It aims at certifying the methodology of calculating
(average) personnel costs and overhead rates
• Waives the obligation of certificates for interim payments
• Simplified certificate for final payments
• Valid throughout FP7, on a voluntary basis, must be
accepted by the EC
• Particularly aimed at legal entities with multiple
participation
Certification on
financial statements
Under FP7 we do not talk anymore about audit certificates but
about certificate on financial statements (CFS)
Certificate on financial statements:
• Mandatory when requested funding reaches 375,000
Euro per beneficiary (except for project of 2 years or
less: CFS submitted at the end)
• If above the threshold, mandatory for every beneficiary,
except if a certification on the methodology is provided
Risk avoidance mechanism (1)
Participant Guarantee Fund (“the Fund”):
• All beneficiaires contribute to the Fund to insure
against losses of a defaulting participant
• The contribution shall not exceed 5% of the EC
financial contribution due to each participant
• Financial interests generated by the Fund will serve to cover
financial risk
• In principle this amount will be reimbursed at the end of
the action
Terminology
Sources: Financial Regulation/Implementing Rules, FP7
and Rules for Participation
• “Contract” becomes “Grant Agreement”
• “Contractor” becomes “Beneficiary”
• “Instruments” become “Funding Schemes”
• “Audit certificate” becomes “Certificate on
Financial Statement”
• The results of the project (knowledge in FP6)
becomes “Foreground”
• Pre-existing know-how becomes “Background”
Consortium agreement
• Unless exempted by the call for proposals,
participants will have to draw up a
“consortium agreement”, to govern the
following:
• (a) The internal organisation of the consortium
• (b) The distribution of the Community financial contribution
• (c) Additional rules on dissemination and use including
intellectual property rights arrangements, as appropriate
• (d) The settlement of internal disputes.
Who evaluates proposals
How to become evaluator for FP7
Cooperation
The Commission invites individuals to apply as
prospective independent experts in order to be
included in its database of experts for the
Seventh Framework Programme
http://cordis.europa.eu/emmfp7
Who evaluates proposals
How to become evaluator for FP7
Ideas
The Commission has invited the Member States to
submit candidates as independent experts in order
to be included in its specific database as panel
Chairs and panel members and a pool of referees.
Panel Chairs are expected to be internationally
recognised, senior scientists in their fields.
Panel members are expected to be senior scientists in
their fields, actively pursuing research at the front
line.
Further information
Information research programmes projects:
http://cordis.europa.eu/fp7
EU research:
http://europa.eu.int/comm/research
RTD info magazine:
http://europa.eu.int/comm/research/rtdinfo
Single Helpdesk:
Research Enquiries Service
http://ec.europa.eu/research/enquiries